NASTAD logo over a stack of newspapers

NASTAD Announces 2022-2023 Board of Directors

FOR IMMEDIATE RELEASE: June 1, 2022

CONTACT: Kyle Taylor, Director, Communications, NASTAD

NASTAD Announces 2022-2023 Board of Directors

Washington, DC – Monday, May 23, NASTAD, a leading non-partisan non-profit association that represents public health officials who administer HIV and hepatitis programs in the U.S., announced its 2022-2023 Board of Directors. NASTAD is governed by a 23-member, elected Board charged with making policy and program decisions on behalf of the full membership.

The 2022-2023 Board of Directors includes:  

Officers (Executive Committee)

  • Elizabeth Crutsinger-Perry (Washington) Chair
  • Ricardo Fernández (Arizona) Vice-Chair
  • Debra Guilbault (Kansas) Secretary
  • Jeremy Turner (Indiana) Treasurer
  • David Kern (Chicago) Chair-elect
  • Stephen Lee, NASTAD Executive Director (ex-officio, non-voting)

Board Members

  • Vontrese McGhee, Alabama
  • Marisa Ramos, California
  • Clover Barnes, District of Columbia
  • Emma Spencer, Florida
  • Jamila Ealey, Georgia
  • Thaddeus Pham, Hawaii
  • Marlene McNeese, Houston
  • Randy Mayer, Iowa
  • Samuel Burgess, Louisiana
  • Dawn Fukuda, Massachusetts
  • Kathryn Macomber, Michigan
  • Christine Jones, Minnesota
  • Melverta Bender, Mississippi
  • Lorlette Moir, New Hampshire
  • Ka’leef Morse, New Jersey
  • Jacquelyn Clymore, North Carolina
  • Ali Mansaray, South Carolina

“I am honored to welcome the 2022-2023 NASTAD Board of Directors,” said Stephen Lee, NASTAD Executive Director. “I look forward to working alongside these individuals and witnessing all that they can accomplish toward Elizabeth Crutsinger-Perry’s Chair’s Challenge, Implementing Strategic Visions in order to End the Epidemics.”

###

About NASTAD Founded in 1992, NASTAD is a leading non-partisan non-profit association that represents public health officials who administer HIV and hepatitis programs in the U.S. Our singular mission is to end the intersecting epidemics of HIV, viral hepatitis, and related conditions. We do this work by strengthening governmental public health through advocacy, capacity building, and social justice.